Skip to main content
Erschienen in: Journal of Infection and Chemotherapy 5/2012

01.10.2012 | Original Article

Effects of lactoferricin B against keratitis-associated fungal biofilms

verfasst von: Jayangshu Sengupta, Suman Saha, Archana Khetan, Sujoy K. Sarkar, Santi M. Mandal

Erschienen in: Journal of Infection and Chemotherapy | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Biofilms are considered as the most important developmental characteristics in ocular infections. Biofilm eradication is a major challenge today to overcome the incidence of drug resistance. This report demonstrates the in vitro ability of biofilm formation on contact lens by three common keratitis-associated fungal pathogens, namely, Aspergillus fumigatus, Fusarium solani, and Candida albicans. Antifungal sensitivity testing performed for both planktonic cells and biofilm revealed the sessile phenotype to be resistant at MIC levels for the planktonic cells and also at higher concentrations. A prototype lens care solution was also found to be partially effective in eradication of the mature biofilm from contact lenses. Lactoferricin B (Lacf, 64 μg/ml), an antimicrobial peptide, exhibited almost no effect on the sessile phenotype. However, the combinatory effect of Lacf with antifungals against planktonic cells and biofilms of three fungal strains that were isolated from keratitis patients exhibited a reduction of antifungal dose more than eightfold. Furthermore, the effect of Lacf in lens care solution against biofilms in which those strains formed was eradicated successfully. These results suggest that lactoferricin B could be a promising candidate for clinical use in improving biofilm susceptibility to antifungals and also as an antibiofilm-antifungal additive in lens care solution.
Literatur
1.
Zurück zum Zitat Agrawal V, Biswas J, Madhavan HN, Mangat G, Reddy MK, Saini, et al. Current perspectives in infectious keratitis. Ind J Ophthalmol. 1994;42:171–92. Agrawal V, Biswas J, Madhavan HN, Mangat G, Reddy MK, Saini, et al. Current perspectives in infectious keratitis. Ind J Ophthalmol. 1994;42:171–92.
2.
Zurück zum Zitat Saha S, Banerjee D, Khetan A, Sengupta J. Epidemiological profile of fungal keratitis in urban population of West Bengal, India. Oman J Ophthalmol. 2009;2:114–8.PubMedCrossRef Saha S, Banerjee D, Khetan A, Sengupta J. Epidemiological profile of fungal keratitis in urban population of West Bengal, India. Oman J Ophthalmol. 2009;2:114–8.PubMedCrossRef
3.
Zurück zum Zitat Srinivasan M, Gonzales CA, George C. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol. 1997;81:965–71.PubMedCrossRef Srinivasan M, Gonzales CA, George C. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol. 1997;81:965–71.PubMedCrossRef
4.
Zurück zum Zitat Chang DC, Grant GB, O’Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953–63.PubMedCrossRef Chang DC, Grant GB, O’Donnell K, Wannemuehler KA, Noble-Wang J, Rao CY, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953–63.PubMedCrossRef
5.
Zurück zum Zitat Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867–73.PubMedCrossRef Khor WB, Aung T, Saw SM, Wong TY, Tambyah PA, Tan AL, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867–73.PubMedCrossRef
6.
Zurück zum Zitat Sun Y, Chandra J, Mukherjee P, Szczotka-Flynn L, Ghannoum MA, Pearlman E, et al. Model of contact lens-associated Fusarium keratitis. Invest Ophthalmol Vis Sci. 2010;51:1511–6.PubMedCrossRef Sun Y, Chandra J, Mukherjee P, Szczotka-Flynn L, Ghannoum MA, Pearlman E, et al. Model of contact lens-associated Fusarium keratitis. Invest Ophthalmol Vis Sci. 2010;51:1511–6.PubMedCrossRef
7.
Zurück zum Zitat Holden BA, Sankaridurg PR, Sweeney DF, Stretton S, Naduvilath TJ, Rao GN. Microbial keratitis in prospective studies of extended wear with disposable hydrogel contact lenses. Cornea. 2005;24:156–61.PubMedCrossRef Holden BA, Sankaridurg PR, Sweeney DF, Stretton S, Naduvilath TJ, Rao GN. Microbial keratitis in prospective studies of extended wear with disposable hydrogel contact lenses. Cornea. 2005;24:156–61.PubMedCrossRef
8.
Zurück zum Zitat Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.PubMedCrossRef Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.PubMedCrossRef
9.
Zurück zum Zitat De Lucca AJ, Walsh TJ. Antifungal peptides: origin, activity, and therapeutic potential. Rev Iberoam Micol. 2000;17:116–20. De Lucca AJ, Walsh TJ. Antifungal peptides: origin, activity, and therapeutic potential. Rev Iberoam Micol. 2000;17:116–20.
10.
Zurück zum Zitat Mandal SM, Migliolo L, Franco OL, Ghosh AK. Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation. Peptides. 2011;32:1741–7.PubMedCrossRef Mandal SM, Migliolo L, Franco OL, Ghosh AK. Identification of an antifungal peptide from Trapa natans fruits with inhibitory effects on Candida tropicalis biofilm formation. Peptides. 2011;32:1741–7.PubMedCrossRef
11.
Zurück zum Zitat Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci. 2005;62:2588–98.PubMedCrossRef Gifford JL, Hunter HN, Vogel HJ. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell Mol Life Sci. 2005;62:2588–98.PubMedCrossRef
12.
Zurück zum Zitat Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture and drug resistance. J Bacteriol. 2001;183:5385–94.PubMedCrossRef Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture and drug resistance. J Bacteriol. 2001;183:5385–94.PubMedCrossRef
13.
Zurück zum Zitat Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol. 1998;36:1450–2.PubMed Hawser SP, Norris H, Jessup CJ, Ghannoum MA. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol. 1998;36:1450–2.PubMed
14.
Zurück zum Zitat Mowat E, Butcher J, Lang S, Williams C, Ramage G. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol. 2007;56:1205–12.PubMedCrossRef Mowat E, Butcher J, Lang S, Williams C, Ramage G. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol. 2007;56:1205–12.PubMedCrossRef
15.
Zurück zum Zitat Pierce CG, Uppuluri P, Tristan AR, Wormley FR Jr, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494–500.PubMedCrossRef Pierce CG, Uppuluri P, Tristan AR, Wormley FR Jr, Mowat E, Ramage G, Lopez-Ribot JL. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc. 2008;3:1494–500.PubMedCrossRef
16.
Zurück zum Zitat National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
17.
Zurück zum Zitat Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49:253–62.PubMedCrossRef Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49:253–62.PubMedCrossRef
18.
Zurück zum Zitat Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, Pearlman E, et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52:171–82.PubMedCrossRef Imamura Y, Chandra J, Mukherjee PK, Lattif AA, Szczotka-Flynn LB, Pearlman E, et al. Fusarium and Candida albicans biofilms on soft contact lenses: model development, influence of lens type, and susceptibility to lens care solutions. Antimicrob Agents Chemother. 2008;52:171–82.PubMedCrossRef
19.
Zurück zum Zitat Kucharíkova S, Tournu H, Lagrou K, van Dijck P, Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol. 2011;60:1261–9.PubMedCrossRef Kucharíkova S, Tournu H, Lagrou K, van Dijck P, Bujdáková H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin. J Med Microbiol. 2011;60:1261–9.PubMedCrossRef
20.
Zurück zum Zitat Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology. 2000;146:547–9.PubMed Xu KD, McFeters GA, Stewart PS. Biofilm resistance to antimicrobial agents. Microbiology. 2000;146:547–9.PubMed
21.
Zurück zum Zitat Ramage G, Walle KV, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2000;45:2475–9.CrossRef Ramage G, Walle KV, Wickes BL, López-Ribot JL. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2000;45:2475–9.CrossRef
22.
Zurück zum Zitat Lynch S, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2000;59:415–28.CrossRef Lynch S, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med. 2000;59:415–28.CrossRef
23.
Zurück zum Zitat Bellamy W, Yamauchi K, Wakabayashi H, Takase M, Takakura N, Simamura S, et al. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett Appl Microbiol. 1994;18:230–3.CrossRef Bellamy W, Yamauchi K, Wakabayashi H, Takase M, Takakura N, Simamura S, et al. Antifungal properties of lactoferricin B, a peptide derived from the N-terminal region of bovine lactoferrin. Lett Appl Microbiol. 1994;18:230–3.CrossRef
24.
Zurück zum Zitat Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother. 1998;42:1587–91.PubMed Wakabayashi H, Abe S, Teraguchi S, Hayasawa H, Yamaguchi H. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob Agents Chemother. 1998;42:1587–91.PubMed
25.
Zurück zum Zitat Lupetti A, Paulusma-Annema A, Welling MW, Senesi S, van Dissel JT, Nibbering P. Candidacidal activities of human lactoferrin peptides derived from the N-terminus. Antimicrob Agents Chemother. 2000;44:3257–63.PubMedCrossRef Lupetti A, Paulusma-Annema A, Welling MW, Senesi S, van Dissel JT, Nibbering P. Candidacidal activities of human lactoferrin peptides derived from the N-terminus. Antimicrob Agents Chemother. 2000;44:3257–63.PubMedCrossRef
26.
Zurück zum Zitat Ueta E, Tanida T, Osaki T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J Pept Res. 2001;57:240–9.PubMedCrossRef Ueta E, Tanida T, Osaki T. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils. J Pept Res. 2001;57:240–9.PubMedCrossRef
Metadaten
Titel
Effects of lactoferricin B against keratitis-associated fungal biofilms
verfasst von
Jayangshu Sengupta
Suman Saha
Archana Khetan
Sujoy K. Sarkar
Santi M. Mandal
Publikationsdatum
01.10.2012
Verlag
Springer Japan
Erschienen in
Journal of Infection and Chemotherapy / Ausgabe 5/2012
Print ISSN: 1341-321X
Elektronische ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-012-0398-3

Weitere Artikel der Ausgabe 5/2012

Journal of Infection and Chemotherapy 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.